Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q4F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,107
Award facts
- Contract value 100% obligated
- $11,107.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,107.12 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit of use packaging), with an ultimate completion date of December 31, 2025. This non-set-aside competitive award was issued on December 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, representing a critical pharmaceutical supply need within the federal medical procurement system.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical supply chains, supplying medications, vaccines, and medical devices across multiple therapeutic domains to support military healthcare systems and other government healthcare customers including the Defense Health Agency and U.S. Coast Guard. The company's portfolio of DLA contracts demonstrates its capability to fulfill federal procurement requirements across a wide spectrum of pharmaceutical products through competitive, open-market awards.
Quick answers
Who was awarded contract SPE2DR26F9Q4F?
SPE2DR26F9Q4F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F9Q4F worth?
The government has obligated $11,107 on SPE2DR26F9Q4F.
Is contract SPE2DR26F9Q4F an order under another contract?
Yes. SPE2DR26F9Q4F is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q4F competed?
The extent of competition for SPE2DR26F9Q4F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award